C9orf72 and amyotrophic lateral sclerosis: However, conceptually we disfavoured a heterozygous line, albeit closer to the ALS clinic because the purpose of our KO lines was not to clinically mimic the LOF of C9ORF72 by carefully fine-tuning its levels moderately down to the levels seen in clinical patients.